BioCryst Pharmaceuticals
BCRX
#4646
Rank
C$2.32 B
Marketcap
$11.11
Share price
2.32%
Change (1 day)
60.47%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of December 2024 : C$1.16 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is C$1.16 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2024-12-31C$1.16 B6.04%
2023-12-31C$1.09 B8.78%
2022-12-31C$1.00 B33.08%
2021-12-31C$0.75 B112.14%
2020-12-31C$0.35 B222.34%
2019-12-31C$0.11 B31.28%
2018-12-31C$84.21 M22.41%
2017-12-31C$68.79 M-4.71%
2016-12-31C$72.19 M72.45%
2015-12-31C$41.86 M20.25%
2014-12-31C$34.81 M9.02%
2013-12-31C$31.93 M7.05%
2012-12-31C$29.83 M-2.24%
2011-12-31C$30.51 M
2000-12-31C$0.01 M
1997-12-31C$0.14 M-65.23%
1996-12-31C$0.41 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$0.96 B-16.85%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.93 B 66.07%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.15 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.33 B-71.51%๐Ÿ‡บ๐Ÿ‡ธ USA
C$38.45 B 3,202.78%๐Ÿ‡บ๐Ÿ‡ธ USA
C$5.48 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
C$30.68 B 2,535.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$0.95 B-17.93%๐Ÿ‡บ๐Ÿ‡ธ USA
C$15.96 M-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA